| 000 | 01328 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514060045.0 | ||
| 264 | 0 | _c20031010 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a0253-5068 | ||
| 024 | 7 |
_a10.1159/000066956 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKalousová, M | |
| 245 | 0 | 0 |
_aAdvanced glycation end products and advanced oxidation protein products in hemodialyzed patients. _h[electronic resource] |
| 260 |
_bBlood purification _c2002 |
||
| 300 |
_a531-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aChloramines _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycation End Products, Advanced _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOxidative Stress |
| 650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
| 650 | 0 | 4 | _aSpectrometry, Fluorescence |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aZima, T | |
| 700 | 1 | _aTesar, V | |
| 700 | 1 | _aLachmanová, J | |
| 773 | 0 |
_tBlood purification _gvol. 20 _gno. 6 _gp. 531-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000066956 _zAvailable from publisher's website |
| 999 |
_c12364962 _d12364962 |
||